eISSN: 1731-2531
ISSN: 1642-5758
Anaesthesiology Intensive Therapy
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search

Open access

without publication fees

Journal integrated with

integrated with publons
5/2024
vol. 56
 
Share:
Send email
Share:
Original article

Prevalence of multidrug-resistant organisms in intensive care unit patients and rate of subsequent bacteraemia: a 5-year study

Moncompu Subramanian Ramachandran
1
,
Indunil Sandaradura
2, 3
,
Vineet Nayyar
4, 5

  1. Intensive Care Unit, Central Coast Local Health District, New South Wales, Australia
  2. Centre for Infectious Diseases and Microbiology, Australia
  3. University of Sydney School of Medicine, Australia
  4. University of Sydney, Australia
  5. Intensive Care Services, Westmead Hospital, Westmead, New South Wales, Australia
Anaesthesiol Intensive Ther 2024; 56, 5: 277–284
DOI: https://doi.org/10.5114/ait.2024.146641
Online publish date: 2025/01/17
Article file
- Prevalence of multidrug.pdf  [0.15 MB]
Get citation
 
PlumX metrics:
 
1. Melzer M, Petersen I. Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J Infect 2007; 55: 254-259. DOI: 10.1016/j.jinf.2007.04.007.
2. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in the intensive care units. JAMA 2009; 302: 2323-2329. DOI: 10.1001/jama.2009.1754.
3. de Kraker ME, Davey PG, Grundmann H; BURDEN study group. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteraemia: Estimating the burden of antibiotic resistance in Europe. PLoS Med 2011; 8: e1001104. DOI: 10.1371/journal.pmed.1001104.
4. Reddy P, Malczynski M, Obias A, Reiner S, Jin N, Huang J, et al. Screening for extended–spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteraemia. Clin Infect Dis 2007; 45: 846-852. DOI: 10.1086/521260. PMID:17806048.
5. Ting SW, Lee CH, Liu JW. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteraemia: a retrospective propensity-matched case control study. J Microbiol Immunol Infect 2018; 51: 621-628. DOI: 10.1016/j.jmii.2016. 08.022.
6. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118: 146-155. DOI: 10.1378/chest.118.1.146.
7. Azim A, Dwivedi M, Rao P, Baronia AK, Singh RK, Prasad KN, et al. Epidemiology of bacterial colonisation at intensive care unit admission with emphasis on extended-spectrum beta-lactamase- and metallo-beta-lactamase-producing Gram-negative bacteria – an Indian experience. J Med Microbiol 2010; 59 (Pt 8): 955-960. DOI: 10.1099/jmm.0.018085-0.
8. Flokas ME, Alevizakos M, Shehadeh F, Andreatos N, Mylonakis E. Extended-spectrum β-lactamase-producing Enterobacteriaceae colonisation in long-term care facilities: a systematic review and meta-analysis. Int J Antimicrob Agents 2017; 50: 649-656. DOI: 10.1016/ j.ijantimicag.2017.08.003.
9. Danboy CE, Kim S, Chen M, Ahn KW, Ardura MI, Brown V, et al. Incidence, risk factors, and outcomes of patients who develop mucosal barrier injury – laboratory confirmed bloodstream infections in the first 100 days after allogeneic hematopoietic stem cell transplant. JAMA Netw Open 2020; 3: e1918668. DOI: 10.1001/jamanetworkopen.2019.18668.
10. MacFie J, O’Boyle C, Mitchell CJ, Buckley PM, Johnstone D, Sudworth P. Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 1999; 45: 223-228. DOI: 10.1136/gut.45.2.223.
11. Lee NY, Lee HC, Ko NY, Chang CM, Shih HI, Wu CJ, Ko WC. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumenii bacteraemia. Infect Control Hosp Epidemiol 2007; 28: 713-719. DOI: 10.1086/517954. PMID: 17520546.
12. Denis B, Lafaurie M, Donay JL, ontaine JP, Oksenhendler E, Raffoux E, et al. Prevalence, risk factors and outcome of extended spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five year study. Int J Infect Dis 2015; 39: 1-6. DOI: 10.10/j.ijid.2015.07.010.
13. Edmond MB, Ober JF, Weinbaum DL, Pfaller MA, Hwang T, Sanford MD, Wenzel RP. Vancomycin-resistant Enterococcus faecium: risk factors for infection. Clin Infect Dis 1995; 20: 1126-1133. DOI: 10.1093/clinids/20.5.1126.
14. Ford CD, Lopansri BK, Haydoura S, Snow G, Dascomb KK, Asch J, et al. Frequency, risk factors and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukaemia: Different patterns in patients with acute myelogenous and acute lymphoblastic leukaemia. Infect Control Hosp Epidemiol 2015; 36: 47-53. DOI: 10.1017/ice.2014.3.
15. Arnan M, Gudiol C, Calatayud L, Liñares J, Dominguez MÁ, Batlle M, et al. Risk factors for and clinical relevance of faecal extended-spectrum beta-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropaenic patients with haematological malignancies. Eur J Clin Microbiol Infect Dis 2011; 30: 355-360. DOI: 10.1007/s10096-010-1093-x.
16. Vehreschild MJGT, Hamprecht A, Peterson L, Schubert S, Häntschel M, Peter S, et al. A multicentre cohort study on colonisation and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies. J Antimicrob Chemother 2014; 69: 3387-3392. DOI: 10.1093/jac/dku305.
17. Liss BJ, Vehreschild JJ, Cornely OA, Hallek M, Fätkenheuer G, Wisplinghoff H, et al. Intestinal colonization and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase producing enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection 2012; 40: 613-619. DOI: 10.1007/s15010-012-0269-y.
18. Alevizakos M, Karanika S, Detsis M, Mylonakis E. Colonisation with extended-spectrum-beta-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis. Int J Antimicrob Agents 2016; 48: 647-654. DOI: 10.1016/j.ijantimicag.2016.08.021.
19. Kanagasingham KC, Ho KM, Robinson JO. Positive nasal Staphylococcus aureus polymerase chain reaction assay is not sensitive in predicting concurrent or subsequent Staphylococcus aureus infection in critically ill patients. Anaesth Intensive Care 2020; 48: 196-202. DOI: 10.1177/0310057X20911925.
20. Clinical Excellence Commission. Infection prevention and control practice handbook. Clinical Excellence Commission; 2020. https://www.cec.health.nsw.gov.au/__data/assets/pdf_file/0010/383239/IPC-Practice-Handbook-2020.PDF.
21. Teixeira PJZ, Seligman R, Hertz FT, Cruz DB, Fachel JMG. Inadequate treatment of ventilator associated pneumonia: risk factors and impact on outcomes. J Hosp Infect 2007; 65: 361-367. DOI: 10.1016/ j.jhin.2006.12.019.
This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.